Buscar resultados de ensayos clínicos

Patrocinado por

Leiomyomatosis - 26 Studies Found

Estado Estudiar
Not yet recruiting Nombre del estudio: LAM Pilot Study With Imatinib Mesylate
Condición: Lymphangioleiomyomatosis
Fecha: 2017-04-24
Intervenciones:
  • Drug: Imatinib Mesylate 400Mg Capsule

Completed Nombre del estudio: Safety of Simvastatin in LAM and TSC
Condición:
  • Lymphangioleiomyomatosis
  • Tuberous Sclerosis Complex

Fecha: 2014-01-23
Intervenciones: Drug: Simvastatin Eligible patients will be assigned to receive 20 mg of simvastatin once daily for a pe
Completed Nombre del estudio: COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC
Condición: Lymphangioleiomyomatosis (LAM)
Fecha: 2015-06-25
Intervenciones: Drug: Celecoxib We will perform a pilot clinical trial to investigate the safety and tolerability of cel
Completed Nombre del estudio: Lymphangioleiomyomatosis (LAM) Registry
Condición:
  • Lung Diseases
  • Lymphangiomyomatosis

Fecha: 2000-05-25
Not yet recruiting Nombre del estudio: Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial
Condición: Dyspnea
Fecha: 2017-05-10
Intervenciones: Drug: Sirolimus mTOR inhibitor or placebo Other Name
COMPLETED Nombre del estudio: Discovery of Sirolimus Sensitive Biomarkers in Blood
Condición: Lymphangioleiomyomatosis
Fecha: 2025-08-05
Intervenciones: Patients with LAM, whose treating physicians have decided that they need to start treatment with sirolimus will be referred to the NIH Clinical Center
<<< Previous